BioPorto CFO switches to Novo-owned company
Danish biotech company BioPorto will have a new person handling its financial operations from the turn of the month, as its current finance chief is leaving to join a company owned by the Novo-group.
BY STEFAN SINGH KAILAY
From the close of this month, Otto Rasmussen will switch biotech companies with a move from BioPorto to the Novo-owned Xellia Pharmaceuticals. He joined BioPorto as CFO in January 2014 and thus ends up serving just one year in the biotech.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Kolding: It lived up to all our criteria
For abonnenter
Xelia buys US facilitites
For abonnenter
“I‘m certainly not bitter, but maybe a bit disappointed”
For abonnenter
